A Virtual Forum Designed to Address Clinical Challenges with the Goal to Improve Patient Outcomes

September 22, 2021 – September 25, 2021

ACCREDITATION STATEMENT

[JALOGO] [Medscape] In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [bold]For Full Conference Attendance:[/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 13.0 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 13.0 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists:[/bold] Medscape designates this continuing education activity for Knowledge-based 13.0 contact hours and 1.3 CEUs. See individual session Universal Activity numbers below. [bold]Session I [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 1.5 [italic]AMA PRA Category 1 Credit(s)™ [/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 1.5 contact hours and 0.15 CEUs. Universal Activity number [italic]to be determined[/italic]. [bold]Session II [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 1.5 [italic]AMA PRA Category 1 Credit(s)™ [/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 1.5 contact hours and 0.15 CEUs. Universal Activity number [italic]to be determined[/italic]. [bold]Session III [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 1.5 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 1.5 contact hours and 0.15 CEUs. Universal Activity number [italic]to be determined[/italic]. [bold]Session IV [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 1.5 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 1.5 contact hours and 0.15 CEUs. Universal Activity number [italic]to be determined[/italic]. [bold]Session V [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 1.5 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 1.5 contact hours and 0.15 CEUs. Universal Activity number [italic]to be determined[/italic]. [bold]Session VI [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 1.5 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 1.5 contact hours and 0.15 CEUs. Universal Activity number [italic]to be determined[/italic]. [bold]Session VII [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 2.5 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 2.5 contact hours and 0.25 CEUs. Universal Activity number [italic]to be determined[/italic]. [bold]Session VIII [/bold] [bold]For Physicians[/bold] Medscape, LLC designates this live event for a maximum of 1.5 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs Nursing pharmacology content hours to be determined. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 1.5 contact hours and 0.15 CEUs. Universal Activity number [italic]to be determined[/italic].

LEARNING OBJECTIVES


After participating in these activities, learners will demonstrate

Increased knowledge regarding the

  • Current treatment approaches for patients with hematologic malignancies
  • Adverse events associated with current therapies for patients with hematologic malignancies
  • Emerging treatment strategies for hematologic malignancies

Greater competence related to using biomarkers to guide therapy for patients with hematologic malignancies

Greater confidence in their ability to personalize treatment for patients with hematologic malignancies